Silvana G. Jirka
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In Vivo Phage Display for the Identification of Muscle Homing Peptides to Improve the Delivery of Phosphorodiamidate Morpholino Oligomers for Duchenne Muscular Dystrophy Therapy.
Journal: Nucleic acid therapeutics
Published: August 29, 2025
Guide to Selection of Muscle-Homing Peptides After in Vivo Phage Display Biopanning.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Using muscle homing peptide CyPep10 to deliver phosphorodiamidate morpholino oligomers in the mdx mouse.
Journal: Molecular therapy. Nucleic acids
Published: November 29, 2024
Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll-Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells.
Journal: Clinical and translational science
Published: October 18, 2019
Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 05, 2016
An update on RNA-targeting therapies for neuromuscular disorders.
Journal: Current opinion in neurology
Published: August 18, 2015
Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy.
Journal: Molecular therapy. Nucleic acids
Published: May 07, 2015
Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.
Journal: Nucleic acid therapeutics
Published: December 11, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026